PlainPill

Injectable Glutathione

Based on 4 first-hand reports and 6 meta-analyses & systematic reviews in the medical literature. Ranked #2068 of 3,539 overall.

14
User score
Mostly negative
25% positive0% mixed25% negative50% unclear

Of reports that state an outcome, 50% are positive.

Clinical research
BModerate research base
6
meta-analyses
0
RCTs
0
papers

What Injectable Glutathione does, according to users

Of the people who reported each effect, the share who said it got better.

No specific effects reported yet.
betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

BModerate research base

At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found.

Zhongguo Zhong Yao Za Zhi · 2021 · Meta-analysis / systematic review
[Systematic review and Meta-analysis of efficacy and safety of Compound Glycyrrhizin Injection in improving chronic hepatitis B liver damage]

Conclusion: Based on the results, CGI has a certain effect in improving CHB liver damage, but the evidence is not enough to prove that CGI would cause serious adverse events. In the future, more well-designed and strictly-enforced RCT with an adequate sample size are needed to further evaluate the effect CGI in alleviating CHB liver damage.

PubMed 33645037 ↗
J Assist Reprod Genet · 2022 · Meta-analysis / systematic review
Cumulus cell antioxidant system is modulated by patients' clinical characteristics and correlates with embryo development

Conclusion: Through a simple and non-invasive analysis, the evaluation of redox enzymes in cumulus cells could be used to predict embryo development, in a personalized matter in specific patient groups, indicating top-quality oocytes and improving success rates in in vitro fertilization treatments.

PubMed 35469374 ↗
Front Pharmacol · 2025 · Meta-analysis / systematic review
Efficacy and safety of puerarin injection as an adjunctive therapy for chronic heart failure: a systematic review and meta-analysis

Conclusion: This meta-analysis suggests that adjunctive puerarin injection with conventional therapy may provide comprehensive benefits for chronic heart failure management, including improved clinical outcomes, enhanced cardiac function, attenuated ventricular remodeling, optimized hemodynamic performance, and reduced oxidative stress, while maintaining a safety profile comparable to conventional therapy. However, due to the suboptimal quality and some degree of heterogeneity in the existing evidence, there is a need for more high-quality studies to provide more reliable evidence for its future clinical

PubMed 40391374 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

No doses stated in the reports so far.

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

More supplements

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate